Drug Index



Mechanism :

Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. Cephalosporins are bactericidal because of their inhibition of cell-wall synthesis.

Indication :

• Pseudomonas infection

Contraindications :

Ceftazidime is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.

Dosing :

Neonates: <7 days or those >7 days but <1200 gm: 50 mg/kg/dose IM/IV every 12 hourly.

>7 days: 50 mg/kg/dose IM/IV every 8 hourly.

1 month-12 years: 30-50 mg/kg IV every 8 hours; maximum dose: 6 g/day.

>12 years: 1-2 g IV every 8 hours.

Adverse Effect :

Phlebitis, pruritus, rash, fever, toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, diarrhea, nausea, vomiting and abdominal pain.

Interaction :

Nephrotoxicity: Concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide.
Chloramphenicol: Antagonistic to beta-lactam antibiotics, including ceftazidime.

03/11/2020 00:51:11 Ceftazidime
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0